HealthCare Global Enterprises Ltd - 539787 - Announcement under Regulation 30 (LODR)-Investor Presentation
Presentation on the Financial Results of the Company for the quarter and half year ended September 30, 202210-11-2022
10-11-2022
HealthCare Global Enterprises Ltd - 539787 - Disclosure Under Regulation 32 (1) Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Equirements) Regulations, 2015
Statement of deviation or variation under Regulation 32 (1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as on September 30, 2022, pursuant to the preferential allotment of equity shares upon exercise of warrants convertible into equity shares of the Company, approved by the Board on December 06, 2021 and December 08, 2021.10-11-2022
HealthCare Global Enterprises Ltd - 539787 - Results-Financial Results For Sept 30, 2022
inter-alia to consider, approve and take on record the Unaudited Financial Results (both Standalone and Consolidated) of the Company for the quarter and half year ended September 30, 2022 ('Financial Results').10-11-2022
HealthCare Global Enterprises Ltd - 539787 - Board Meeting Outcome for Unaudited Financial Results Of Healthcare Global Enterprises Limited ('The Company")
Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter and half year ended September 30, 2022 together with Limited Review Report thereon; Issue and allotment of 12,175 (Twelve Thousand One Hundred Seventy Five) equity shares of the Company of INR 10 each, upon exercise of Employee Stock Options in accordance with the existing Employee Stock Option Schemes.10-11-2022
HealthCare Global Enterprises Ltd - 539787 - Intimation Of Earnings Call
Earnings Conference Call has been scheduled on Friday, November 11, 2022, at 11.30 am (IST), to discuss the Unaudited Financial Results of the Company.06-11-2022
HealthCare Global Enterprises Ltd - 539787 - Board Meeting Intimation for Intimation Of Meeting Of Board Of Directors Of Healthcare Global Enterprises Limited
Healthcare Global Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2022 ,inter alia, to consider and approve The meeting of the Board of Directors of the Company will be held on Thursday, November 10, 2022, at the Corporate Office of the Company at No. 3, Tower Block, Unity Building Complex, Mission Road, Bengaluru - 560027, inter-alia to consider, approve and take on record the Unaudited Financial Results (both Standalone and Consolidated) of the Company for the quarter and half year ended September 30, 2022 ('Financial Results').31-10-2022
HealthCare Global Enterprises Ltd - 539787 - Amendment To The Limited Liability Partnership Agreement Entered Into By The Company With Respect To HCG NCHRI Oncology LLP, Subsidiary Of The Company.
The Company has executed an amendment agreement to the Limited Liability Partnership Agreement dated March 20, 2017 ('LLP Agreement'), with Nagpur Cancer Hospital and Research Institute Private Limited ('NCHRI') and Dr. Ajay Mehta, on October 27, 2022 ('Amendment Agreement') amending the capital contribution proportion in HCG NCHRI Oncology LLP ('LLP'), as partners of the LLP.28-10-2022
HealthCare Global Enterprises Ltd - 539787 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Analyst / Institutional Investor meetings18-10-2022
HealthCare Global Enterprises Ltd - 539787 - Announcement Under Regulation 30
Investor Presentation under Regulation 30 and Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201514-10-2022
HealthCare Global Enterprises Ltd - 539787 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74 (5) of SEBI (Depositories and Participants) Regulations, 2018.14-10-2022